The Global Structural Heart Devices Market valued at $6.6 billion in 2021 is set to witness a growth rate of 10% in the next 5 years. The rising geriatric population & corresponding rise in the ...

Boston Scientific has discontinued global sales of its Acurate neo2 and Acurate Prime transcatheter aortic valve replacement ...

Boston Scientific is pulling its latest transcatheter aortic heart valve platform from the worldwide market and said it will ...

Boston Scientific said it still expects to achieve its second-quarter and full-year 2025 sales and adjusted per-share earnings guidance despite the anticipated financial impacts from the ...

New research by Edwards Lifesciences has demonstrated that early intervention for severe aortic stenosis (AS) before symptoms ...

Year to date, shares of Abbott have jumped 18.8%, while those of Medtronic have improved 6.5%. Both the stocks outperformed ...

Medtronic this week announced it received CE Mark approval for an expanded indication of its Evolut Pro+ and Evolut FX TAVI ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced financial results for its fourth quarter (Q4) and fiscal year 2025 (FY25), which ended April 25, 2025.

Philips has launched the VeriSight Pro 3D Intracardiac Echocardiography (ICE) catheter on the European market.

As in the SMART trial, early hemodynamic differences have yet to result in a clinical impact—but it may just be a matter of ...

Of participants, 623 underwent TAVR with a SAPIEN 3 or SAPIEN 3 Ultra valve, while 290 had an Evolut R, PRO or PRO+ valve. The 59 patients with bicuspid valve morphology (92% type 1, 8% type 0) tended ...